Assignee
CSL BEHRING AG
CH·23 granted patents·17 pending applications·121 citations·filing 2005–2025
Top patents by PatentIndex Score
40 records- 0194US7759315B2Treatment of inflammatory conditions of the intestineCSL BEHRING AG·Filed 2005·Granted Jul 20, 2010·89 cites·16 claims
- 0283US10137197B2Process for preparing an immunoglobulin preparationCSL BEHRING AG·Filed 2015·Granted Nov 27, 2018·4 cites·24 claims
- 0383US9534029B2Method of purifying proteinsCSL BEHRING AG·Filed 2013·Granted Jan 3, 2017·3 cites·12 claims
- 0480US10434176B2Immunoglobulin preparation and storage system for an immunoglobulin preparationCSL BEHRING AG·Filed 2016·Granted Oct 8, 2019·4 cites·20 claims
- 0576US12558422B2Immunoglobulin preparation and storage system for an immunoglobulin preparationCSL BEHRING AG·Filed 2022·Granted Feb 24, 2026·0 cites·20 claims
- 0676US9828418B2Process for enriching IgACSL BEHRING AG·Filed 2013·Granted Nov 28, 2017·5 cites·26 claims
- 0775US11312746B2Method and system of protein extractionCSL BEHRING AG·Filed 2019·Granted Apr 26, 2022·2 cites·29 claims
- 0874US12194101B2Process for preparing an immunoglobulin preparationCSL BEHRING AG·Filed 2021·Granted Jan 14, 2025·0 cites·24 claims
- 0971US12144861B2Pharmaceutical product with increased stability comprising immunoglobulinsCSL BEHRING AG·Filed 2015·Granted Nov 19, 2024·2 cites·31 claims
- 1071US9932392B2Prevention of infectionCSL BEHRING AG·Filed 2013·Granted Apr 3, 2018·1 cites·21 claims
- 1171US2025025554A1Pharmaceutical Product With Increased Stability Comprising ImmunoglobulinsCSL BEHRING AG·Filed 2024·Application pending·0 cites
- 1269US9546209B2Treatment of mucositis with immunoglobulinCSL BEHRING AG·Filed 2013·Granted Jan 17, 2017·3 cites·28 claims
- 1368US7491693B2HDL for the treatment of stroke and other ischemic conditionsCSL BEHRING AG·Filed 2007·Granted Feb 17, 2009·5 cites·13 claims
- 1465US10221233B2Compositions comprising secretory-like immunoglobulinsCSL BEHRING AG·Filed 2013·Granted Mar 5, 2019·1 cites·18 claims
- 1564US10144774B2Method for purifying IgGCSL BEHRING AG·Filed 2014·Granted Dec 4, 2018·1 cites·21 claims
- 1662US11419936B2Immunoglobulin preparation and storage system for an immunoglobulin preparationCSL BEHRING AG·Filed 2019·Granted Aug 23, 2022·0 cites·22 claims
- 1762US10918696B2Methods of treatment using hemopexin compositionsCSL BEHRING AG·Filed 2018·Granted Feb 16, 2021·0 cites·20 claims
- 1862US9937229B2Methods of treatment using hemopexin compositionsCSL BEHRING AG·Filed 2016·Granted Apr 10, 2018·0 cites·18 claims
- 1959US2026053729A1Hemopexin formulationsCSL BEHRING AG·Filed 2025·Application pending·0 cites
- 2058US2023055416A1Method and system of protein extractionCSL BEHRING AG·Filed 2022·Application pending·0 cites
- 2157US2018360969A1Immunoglobulin preparationCSL BEHRING AG·Filed 2018·Application pending·0 cites
- 2256US2026069657A1Haptoglobulin for Use in Treating or Preventing Exaggerated Erectile Response or Erectile DysfunctionCSL BEHRING AG·Filed 2023·Application pending·0 cites
- 2355US12325738B2Treatment of CIDPCSL BEHRING AG·Filed 2019·Granted Jun 10, 2025·1 cites·10 claims
- 2454US12396943B2Hemopexin formulationsCSL BEHRING AG·Filed 2018·Granted Aug 26, 2025·0 cites·34 claims
- 2554US2025326822A1Treatment of cidpCSL BEHRING AG·Filed 2025·Application pending·0 cites
- 2653US10829542B2Methods for affecting Salmonella infectionsCSL BEHRING AG·Filed 2017·Granted Nov 10, 2020·0 cites·18 claims
- 2753US2025249437A1Methods of sanitizing and/or regenerating a chromatography mediumCSL BEHRING AG·Filed 2023·Application pending·0 cites
- 2853US2024409612A1Improved purification processCSL BEHRING AG·Filed 2022·Application pending·0 cites
- 2951US2025304655A1Expression System for Producing a Recombinant Haptoglobin (Hp) Beta ChainCSL BEHRING AG·Filed 2022·Application pending·0 cites
- 3050US2025074970A1Method of purifying immunoglobulin g and uses thereofCSL BEHRING AG·Filed 2022·Application pending·0 cites
- 3149US2024336650A1Plasma fractionation by continuous extractionCSL BEHRING AG·Filed 2022·Application pending·0 cites
- 3247US2025297954A1Method of monitoring parameters in turbid solutionsCSL BEHRING AG·Filed 2023·Application pending·0 cites
- 3345US2022025019A1Methods and compositions for preventing or treating acute exacerbations with polyclonal immunoglobulinCSL BEHRING AG·Filed 2019·Application pending·0 cites
- 3444US2024101640A1Cd91 polypeptide for use in detecting hemopexin:heme complexCSL BEHRING AG·Filed 2021·Application pending·0 cites
- 3543US7887797B2Immunoglobulin fractionsCSL BEHRING AG·Filed 2005·Granted Feb 15, 2011·0 cites·16 claims
- 3641US2025339492A1Method of treating or preventing an adverse secondary neurological outcome following a haemorrhagic strokeCSL BEHRING AG·Filed 2022·Application pending·0 cites
- 3740US12559520B2Method for extracting a protein from a precipitate and method for precipitating impuritiesCSL BEHRING AG·Filed 2020·Granted Feb 24, 2026·0 cites·20 claims
- 3838US2017166640A1Cd89 activation in therapyCSL BEHRING AG·Filed 2016·Application pending·0 cites
- 3934US2020055922A1Immunoglobulin products for use in the treatment of chronic inflammatory demyelinating polyneuropathyCSL BEHRING AG·Filed 2018·Application pending·0 cites
- 4031US11471617B2Nebultzation of immunoglobulinCSL BEHRING AG·Filed 2015·Granted Oct 18, 2022·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when CSL BEHRING AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →